Order results by:
| Issue | Title | |
| Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
| A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
| "... (SPMS). To date, there has not been a sufficiently effective therapy for SPMS. Siponimod is a selective ..." | ||
| Online-first | From pathogenesis and research to the treatment of secondary progressive multiple sclerosis in clinical practice: switching from anti-CD20 monoclonal antibody therapy to siponimod (clinical case) | Abstract similar documents |
| E. V. Popova | ||
| "... multiple sclerosis (SPMS) who received therapy with an anti-CD20 monoclonal antibody infusion. The patient ..." | ||
| Vol 16 (2024): (Suppl. 2) | Optimization of therapy in secondary progressive multiple sclerosis | Abstract similar documents |
| A. N. Boyko, S. K. Zyryanov, Ya. V. Vlasov | ||
| "... sclerosis (SPMS). The only drug that has proven its effectiveness in all types of SPMS (with exacerbations ..." | ||
| Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
| N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
| "... of siponimod in a large population of patients with SPMS allows the latter to be recommended for its treatment ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
| Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
| "... components. Only recently, a new drug, siponimod, has been approved for the treatment of SPMS. The lack ..." | ||
| Vol 13, No 1 (2021) | New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis | Abstract similar documents |
| D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva | ||
| "... siponimod (Kiendra® ) into clinical practice for the treatment of patients with secondary progressive MS. ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... retinal structures in remitting (RMS) and secondary-progressive (SPMS) MS phenotypes. Patients ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... MS (PPMS), secondary progressive MS (SPMS) and exacerbations, and highly active MS. Objective ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... MS (RRMS), 9.1±4.2 years in secondary progressive MS (SPMS), and 2.7±1.9 years in primary progressive ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... secondary progressive MS (SPMS), 6 (7%) had rapidly progressive MS (RPMS) and 69 (84%) had highly active MS ..." | ||
| Vol 11, No 4 (2019) | Hippocampal magnetic resonance imaging morphometry and neuropsychological parameters in patients with Alzheimer's disease | Abstract similar documents |
| N. N. Yakhno, N. N. Koberskaya, V. A. Perepelov, D. S. Smirnov, V. I. Solodovnikov, M. I. Trufanov, V. N. Gridin | ||
| "... магнитного поля 3 Тл. Для конвертации изображений применялся программный продукт SPM (Statistical Parametric ..." | ||
| Online-first | Магнитно-резонансная морфометрия гиппокампов и нейропсихологические показатели у пациентов с болезнью Альцгеймера | Abstract similar documents |
| Н. Н. Яхно, Н. Н. Коберская, В. А. Перепелов, Д. С. Смирнов, В. И. Солодовников, М. И. Труфанов, В. Н. Гридин | ||
| "... магнитного поля 3 Тл. Для конвертации изображений применялся программный продукт SPM (Statistical Parametric ..." | ||
| Vol 6, No 2 (2014) | Voxel-based moprhometry in the differential diagnosis of posttraumatic cognitive impairments | Abstract similar documents |
| M.M. Odinak, S.V. Vorobyev, V.А. Fokin, A.Yu. Emelin, V.Yu. Lobzin, A.V. Sokolov | ||
| "... and temporal lobes. A combined comprehensive assessment of the results obtained in the group analysis using SPM ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... progressive MS (PPMS and SPMS, respectively). Currently, there is an active search for MS biomarkers capable ..." | ||
| Vol 9, No 3 (2017) | Chronic pain-associated cognitive impairment | Abstract similar documents |
| N. N. Koberskaya, G. R. Tabeeva | ||
| "... control and the brain regions responsible for key cognitive functions. These data expand the views ..." | ||
| Vol 7, No 4 (2015) | Endovascular treatments for ischemic stroke: Present status and prospects | Abstract similar documents |
| A. V. Savello, D. V. Svistov, V. A. Sorokoumov | ||
| "... by recent investigations, have good prospects. These treatments for IS make it possible to expand ..." | ||
| Vol 17, No 4 (2025) | Infusion anti-B-cell therapy in multiple sclerosis: a comparative analysis of agents within the same class | Abstract similar documents |
| A. N. Boiko, A. D. Kukushkina, S. V. Rogovsky | ||
| "... continues to expand, with the introduction of a new anti-CD20 molecule – divozilumab – approved in Russia ..." | ||
| Vol 15, No 1 (2023) | Modern aspects of diagnosis and treatment of cognitive impairments (literature review) | Abstract similar documents |
| A. B. Lokshina, V. V. Zakharov, N. V. Vakhnina | ||
| "... of these disorders expands the potential for secondary prevention and therapeutic intervention, which can delay ..." | ||
| Vol 14, No 4 (2022) | Cognitive dysfunction in patients with Chiari malformation type 1 and its relationship with the degree of cerebellar tonsil ectopia | Abstract similar documents |
| R. G. Kokurkina, E. G. Mendelevich | ||
| "... The use of neuroimaging diagnostics of Chiari malformation type 1 (CM1) allows us to expand our ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... . It is necessary to expand the microRNA pool, and further study of the subject using larger groups of patients ..." | ||
| 1 - 20 of 20 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
